Methods for handling dropouts in longitudinal clinical trials

被引:21
|
作者
Fitzmaurice, GM [1 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
关键词
dropouts; explanatory analysis; intention-to-treat; missing data; pragmatic analysis; repeated measures;
D O I
10.1111/1467-9574.00222
中图分类号
O21 [概率论与数理统计]; C8 [统计学];
学科分类号
020208 ; 070103 ; 0714 ;
摘要
This paper focuses on the monotone missing data patterns produced by dropouts and presents a review of the statistical literature on approaches for handling dropouts in longitudinal clinical trials. A variety of ad hoc procedures for handling dropouts are widely used. The rationale for many of these procedures is not well-founded and they can result in biased estimates of treatment comparisons. A fundamentally difficult problem arises when the probability of dropout is thought to be related to the specific value that in principle should have been obtained; this is often referred to as informative or non-ignorable dropout. Joint models for the longitudinal outcomes and the dropout times have been proposed in order to make corrections for non-ignorable dropouts. Two broad classes of joint models are reviewed: selection models and pattern-mixture models. Finally, when there are dropouts in a longitudinal clinical trial the goals of the analysis need to be clearly specified. In this paper we review the main distinctions between a "pragmatic" and an "explanatory" analysis. We note that many of the procedures for handling dropouts that are widely used in practice come closest to producing an explanatory rather than a pragmatic analysis.
引用
收藏
页码:75 / 99
页数:25
相关论文
共 50 条
  • [31] Testing for treatment differences with dropouts present in clinical trials - A composite approach
    Shih, WJ
    Quan, H
    STATISTICS IN MEDICINE, 1997, 16 (11) : 1225 - 1239
  • [32] Methods for Missing Data Handling in Randomized Clinical Trials With Nonnormal Endpoints With Application to a Phase III Clinical Trial
    Fan, Chunpeng
    Zhang, Donghui
    Wei, Lynn
    Koch, Gary
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2016, 8 (02): : 179 - 193
  • [33] Factors differentiating dropouts from completers in a longitudinal, multicenter clinical trial
    Moser, DK
    Dracup, K
    Doering, LV
    NURSING RESEARCH, 2000, 49 (02) : 109 - 116
  • [34] Dropouts in tamoxifen prevention trials
    Veronesi, U
    Maisonneuve, P
    Costa, A
    Rotmensz, N
    Boyle, P
    LANCET, 1999, 353 (9148): : 244 - 244
  • [35] Methods for Missing Data Handling in Phase III Clinical Trials with Nonnormal Endpoints and Nonnormal Covariates
    Fan, Chunpeng
    Wei, Lynn
    Koch, Gary G.
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2020, 12 (01): : 68 - 78
  • [36] Handling missing data in clinical trials: An overview
    Myers, WR
    DRUG INFORMATION JOURNAL, 2000, 34 (02): : 525 - 533
  • [37] Handling Missing Data in Clinical Trials: An Overview
    William R. Myers
    Drug information journal : DIJ / Drug Information Association, 2000, 34 (2): : 525 - 533
  • [38] Visualizing Longitudinal Data With Dropouts
    Goenen, Mithat
    AMERICAN STATISTICIAN, 2013, 67 (02): : 97 - 103
  • [39] Identifying Differential Responders and Their Characteristics in Clinical Trials: Innovative Methods for Analyzing Longitudinal Data
    Stull, Donald E.
    Houghton, Katherine
    VALUE IN HEALTH, 2013, 16 (01) : 164 - 176
  • [40] Impact of missing data due to selective dropouts in cohort studies and clinical trials
    Touloumi, G
    Pocock, SJ
    Babiker, AG
    Darbyshire, JH
    EPIDEMIOLOGY, 2002, 13 (03) : 347 - 355